Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
ID: 351108Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $350K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)." This initiative aims to support research focused on developing effective prevention strategies to reduce prenatal alcohol exposure and enhance interventions for individuals affected by Fetal Alcohol Spectrum Disorders (FASD) throughout their lifespan. The funding will be allocated through an Exploratory/Developmental Phased Award mechanism, with the R61 phase dedicated to pilot studies and hypothesis development, while the R33 phase will expand on successful interventions. Interested applicants can apply for a total funding ceiling of $350,000 for the R61 phase and $500,000 per year for the R33 phase, with proposals due by 5:00 PM local time on January 16, 2024, and subsequent deadlines. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), invites proposals for funding under the Notice of Funding Opportunity (NOFO) PAR-24-068, aimed at developing prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD). This funding seeks to support research that reduces prenatal alcohol exposure and enhances interventions for affected individuals, emphasizing exploratory and developmental phases (R61/R33). Key objectives include identifying effective prevention strategies targeting women of childbearing age and evaluating new therapeutic approaches throughout the lifespan of individuals with FASD. The R61 phase supports initial hypothesis development and feasibility studies, while the R33 phase focuses on broader application and evaluation of successful interventions. Applications are due by 5:00 PM local time on specified dates, starting January 16, 2024, with total funding limits of $350,000 for R61 and $500,000 per year for R33. Overall, this initiative represents a significant commitment by the NIH to tackle the public health issues associated with prenatal alcohol exposure, aiming to build a strong evidence base for prevention and intervention efforts that will enhance the lives of individuals impacted by FASD.
    Similar Opportunities
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (FASD)" under the R61/R33 exploratory/developmental phased award mechanism. This initiative aims to support research focused on developing and evaluating prevention strategies to reduce prenatal alcohol exposure and interventions to mitigate the effects of FASD throughout the lifespan. The funding is critical for addressing the public health issue of prenatal alcohol exposure, with a funding cap of $350,000 for the R61 phase (two years) and $500,000 annually for the R33 phase (three years). Interested applicants, including various educational institutions and organizations, must submit their applications by November 17, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R34 Clinical Trial Optional grant program to support research on prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD). The primary objective of this grant is to develop evidence-based strategies aimed at reducing prenatal alcohol exposure and the incidence of FASD, while also conducting preliminary studies necessary for larger-scale projects. This initiative is crucial for advancing public health, particularly in the field of maternal and child health, by addressing the challenges associated with prenatal alcohol exposure. Eligible applicants can receive up to $450,000 over three years, with applications accepted until January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-067.html.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for R34 planning grants aimed at supporting research on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD). This initiative seeks applications that will contribute to evidence-based strategies to reduce prenatal alcohol exposure and improve outcomes for individuals affected by FASD, with a focus on innovative studies that can provide pilot or feasibility data for larger-scale research. The maximum budget for the three-year project period is set at $450,000, and eligible applicants include various higher education institutions, nonprofits, and state and local governments. Interested parties should note that the earliest submission date is January 16, 2025, with the application deadline extending to January 7, 2027; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a Notice of Funding Opportunity (NOFO) titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)." This initiative aims to enhance the HIV prevention toolkit for populations affected by alcohol consumption, focusing on the integration of effective prevention and treatment interventions to reduce the incidence of new HIV infections. The program is particularly relevant for high-risk groups, including men who have sex with men, transgender individuals, and others impacted by alcohol-related HIV transmission, emphasizing the need for innovative strategies to address health disparities. The funding opportunity offers a total estimated program funding of $1.5 million for 2-4 awards, with individual project budgets capped at $450,000, and applications are due by May 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and should refer to the full announcement for detailed application guidelines.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research on Alcohol Treatment, Pharmacotherapy, and Recovery under the R34 Clinical Trial required mechanism. This initiative aims to address the treatment gap for individuals with alcohol use disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing treatment appeal, examining cost structures, studying dissemination of evidence-based approaches, and reducing health disparities. With AUD being a significant global health issue, this funding seeks to improve treatment methods and recovery pathways, particularly for underserved populations. Applications will be accepted starting January 16, 2025, with a maximum project period of three years and direct costs capped at $450,000. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-193.html.
    Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)," aimed at advancing translational research in the field of substance use. This initiative encourages researchers to engage in a two-phase research process, starting with an R61 planning phase lasting up to two years, followed by an R33 phase for larger studies that may extend up to four years, contingent upon meeting specific milestones. The program emphasizes the importance of community stakeholder engagement and mandates a Plan for Enhancing Diverse Perspectives (PEDP) in all proposals to ensure inclusivity in research development. Interested applicants can find more information and submit their proposals by December 14, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Alcohol Treatment, Pharmacotherapy, and Recovery Research grant, specifically under the R01 Clinical Trial Required mechanism. This funding opportunity aims to advance research on Alcohol Use Disorder (AUD) by focusing on various aspects such as medication development, behavioral therapies, recovery mechanisms, and innovative treatment technologies. The NIH emphasizes the importance of addressing AUD, particularly for underserved populations, and seeks projects that translate neuroscience research into practical applications. Interested applicants can apply for a grant with an award ceiling of $500,000, with the application process opening on January 5, 2025, and submissions due by September 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PA-25-163.html.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R34 Clinical Trial mechanism focused on Alcohol Treatment, Pharmacotherapy, and Recovery Research. This initiative aims to enhance understanding and treatment strategies for Alcohol Use Disorder (AUD) through clinical trials, with a particular emphasis on increasing access to treatment, improving treatment appeal, examining cost structures, and addressing health disparities among affected populations. The program is open to a diverse range of applicants, including educational institutions, nonprofits, and government agencies, with funding limits set at $450,000 over a maximum three-year project period. Interested parties must submit their applications by October 16, 2023, and can direct inquiries to grantsinfo@nih.gov for further information.